Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Prostaglandin platelet aggregation

CYP5 synthesizes thromboxane A2, a fatty acid in the arachidonic acid cascade that causes platelet aggregation. Aspirin prevents platelet aggregation because it blocks the cyclooxygenases COX1 and COX2 which catalyze the initial step of the biotransformation of arachidonic acid to thromboxane and prostaglandins. [Pg.926]

The widely used platelet inhibitor aspirin or acetylsalicylic acid, by acetylating the enzyme cyclooxygenase, inhibits platelet function by preventing the formation of thromboxane A2 and the synthesis of prostaglandin I2 (PGI2) (68). Aspirin has been used in combination with other antiplatelet agents such as ticlopidine, which inhibits ADP-induced platelet aggregation (69). [Pg.151]

Srivastava KC. (1986). Isolation and effects of some ginger components of platelet aggregation and eicosanoid biosynthesis. Prostaglandins Leukot Med. 25(2-3) 187-98. [Pg.516]

The capacity to produce prostaglandins, which inhibit platelet aggregation. [Pg.512]

Induction of vasodilation and inhibition of platelet aggregation prostaglandin Ei and its analogues are most commonly employed and are used to treat infants with congenital heart disease ... [Pg.27]

The salicylates are also potent antipyretic agents, with the exception of diflunisal, which is only weakly active. Aspirin acts at two distinct but related sites. It decreases prostaglandin-induced fever in response to pyrogens and induces a decrease in interleukin-1 modulation of the hypothalamic control of body temperature. Thus, the hypothalamic control of body temperature returns, vasodilation occurs, heat dissipates, and fever decreases. Other uses of aspirin include inhibition of platelet aggregation via inhibition of thromboxanes, which has been shown to decrease the incidence of blood clots, myocardial infarction, and transient ischemic attacks. [Pg.313]

S. Moncada, R.J. Gryglewski, S. Bunting, J.R. Vane, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263 (1976) 663. [Pg.658]

ZO053 Srivastava, K. C. Isolation and effect of some ginger component of platelet aggregation and eicosanoid biosynthe- ZO065 sis. Prostaglandins Leukot Med 1986 ... [Pg.546]


See other pages where Prostaglandin platelet aggregation is mentioned: [Pg.50]    [Pg.385]    [Pg.386]    [Pg.10]    [Pg.14]    [Pg.1067]    [Pg.10]    [Pg.169]    [Pg.406]    [Pg.1020]    [Pg.159]    [Pg.196]    [Pg.267]    [Pg.90]    [Pg.136]    [Pg.160]    [Pg.108]    [Pg.160]    [Pg.203]    [Pg.203]    [Pg.198]    [Pg.412]    [Pg.311]    [Pg.229]    [Pg.237]    [Pg.254]    [Pg.340]    [Pg.1059]    [Pg.1362]    [Pg.912]    [Pg.392]    [Pg.319]    [Pg.312]    [Pg.313]    [Pg.737]    [Pg.539]    [Pg.546]    [Pg.31]    [Pg.194]    [Pg.194]    [Pg.519]    [Pg.524]   
See also in sourсe #XX -- [ Pg.192 ]




SEARCH



© 2024 chempedia.info